Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Search Results for "Oral Manifestation Of Anemia"

20:03 EDT 20th April 2014 | BioPortfolio

Original Source: Oral Manifestations of Aplastic Anemia

The purposes of this study are threefold: 1) to evaluate the prevalence and risks of oral complications in patients with aplastic anemia; 2) to evaluate if oral problems in these patients can predict their response to treatment; and 3) to review complications of dental treatment in these patients in order to establish treatment guidelines. This study will be performed through a review of medical charts of 79 patients with aplastic anemia and 67 patients with schizophrenia who...

Matching Channels

Matching News

AstraZeneca in anemia alliance

AstraZeneca and FibroGen have inked an agreement to develop and commercialise FG-4592, a first-in-class oral anemia treatment.

Shield To File ST10 Oral Iron-Deficiency Drug After Strong Phase III Data

Shield Therapeutics will use robust Phase III data for its oral iron-deficiency therapy ST10 to seek marketing approval in Europe in the second half of 2014 for iron-deficiency anemia in inflammatory...

First Patients Enrolled into European CKD-Associated Anemia Trial

Astellas Pharma Europe Ltd. announced that the first European patients have been enrolled into the global ALPINE program being conducted in collaboration with FibroGen Inc., to investigate the safety...

Anemia company Akebia files for IPO

Akebia Therapeutics Inc. (Cambridge, Mass.) filed to raise up to $75 million in an IPO on NASDAQ underwritten by Morgan Stanley; Credit Suisse; UBS; and Nomura. Akebia is evaluating AKB-6548 in a Phas...

New report on global prevalence of anemia

Despite increasing efforts to diagnose and treat anemia worldwide, there remains a surprisingly large global burden of the disease, particularly among young children and women, according to a new repo...

Shield's ST10 meets in Phase III anemia trial in IBD patients

Shield Therapeutics AG (Wollerau, Switzerland) said twice-daily oral ST10 met the primary endpoint of improving mean hemoglobin levels from baseline to week 12 vs. placebo in a Phase III trial to trea...

AMAG slips on Feraheme sNDA update

AMAG Pharmaceuticals Inc. (NASDAQ:AMAG) was off $3.58 (15%) to $20.37 on Thursday after disclosing in an SEC filing that FDA has not yet discussed proposed labeling or postmarketing requirements with...

FDA Rejects Expanded Use for Amag's Anemia Drug

Amag Pharmaceuticals plunged in trading before markets opened Wednesday after the specialty drugmaker said regulators rejected its appeal for the expanded use of its anemia treatment. 

Matching PubMed Articles

Oral manifestations and blood profile in patients with iron deficiency anemia.

Iron deficiency anemia (IDA) is the most common type of anemia. This study evaluated whether IDA patients had specific oral manifestations and a particular blood profile compared to normal controls.

Isolated Cerebellar Involvement in Vitamin B12 Deficiency: A Case Report.

Deficiency of vitamin B12 causes megaloblastic anemia and nervous system demyelination. Structures affected in the nervous system include spinal cord, cranial and peripheral nerves, and brain white ma...

Is the acronym IRIDA acceptable for slow responders to iron in the presence of TMPRSS6 mutations?

Iron refractory iron deficiency anemia (IRIDA) is a recently described autosomal recessive disorder caused by mutations in TMPRSS6, the gene encoding matriptase-2. Patients have inappropriately high l...

A forgotten screening test for iron deficiency anemia: Oral iron absorption test.

In this study, we aimed to investigate the iron absorption defects using the oral iron absorption test (OIAT) in patients with iron deficiency anemia (IDA).

Intravenous iron in postpartum anemia.

To compare effectiveness of intravenous iron-sucrose versus oral ferrous fumarate in postpartum anemia.

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement